Lee Y K, Dell H, Dowhan D H, Hadzopoulou-Cladaras M, Moore D D
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA.
Mol Cell Biol. 2000 Jan;20(1):187-95. doi: 10.1128/MCB.20.1.187-195.2000.
The orphan nuclear hormone receptor SHP interacts with a number of other nuclear hormone receptors and inhibits their transcriptional activity. Several mechanisms have been suggested to account for this inhibition. Here we show that SHP inhibits transactivation by the orphan receptor hepatocyte nuclear factor 4 (HNF-4) and the retinoid X receptor (RXR) by at least two mechanisms. SHP interacts with the same HNF-4 surface recognized by transcriptional coactivators and competes with them for binding in vivo. The minimal SHP sequences previously found to be required for interaction with other receptors are sufficient for interaction with HNF-4, although deletion results indicate that additional C-terminal sequences are necessary for full binding and coactivator competition. These additional sequences include those associated with direct transcriptional repressor activity of SHP. SHP also competes with coactivators for binding to ligand-activated RXR, and based on the ligand-dependent interaction with other nuclear receptors, it is likely that coactivator competition is a general feature of SHP-mediated repression. The minimal receptor interaction domain of SHP is sufficient for full interaction with RXR, as previously described. This domain is also sufficient for full coactivator competition. Functionally, however, full inhibition of RXR transactivation requires the presence of the C-terminal repressor domain, with only weak inhibition associated with this receptor interaction domain. Overall, these results suggest that SHP represses nuclear hormone receptor-mediated transactivation via two separate steps: first by competition with coactivators and then by direct effects of its transcriptional repressor function.
孤儿核激素受体SHP可与多种其他核激素受体相互作用,并抑制它们的转录活性。关于这种抑制作用,已提出了几种机制。在此我们表明,SHP通过至少两种机制抑制孤儿受体肝细胞核因子4(HNF-4)和视黄酸X受体(RXR)的反式激活作用。SHP与转录共激活因子识别的同一HNF-4表面相互作用,并在体内与其竞争结合。先前发现与其他受体相互作用所需的最小SHP序列足以与HNF-4相互作用,尽管缺失结果表明,额外的C末端序列对于完全结合和共激活因子竞争是必需的。这些额外的序列包括与SHP直接转录抑制活性相关的序列。SHP还与共激活因子竞争结合配体激活的RXR,并且基于与其他核受体的配体依赖性相互作用,共激活因子竞争可能是SHP介导的抑制作用的一个普遍特征。如前所述,SHP的最小受体相互作用结构域足以与RXR完全相互作用。该结构域对于完全的共激活因子竞争也足够。然而,在功能上,对RXR反式激活的完全抑制需要C末端抑制结构域的存在,只有微弱的抑制作用与该受体相互作用结构域相关。总体而言,这些结果表明,SHP通过两个独立的步骤抑制核激素受体介导的反式激活:首先通过与共激活因子竞争,然后通过其转录抑制功能的直接作用。